Skip to content

The Effects of Periodontal Therapy on Glycemic Control in Diabetic Patients

The Effects of Non -Surgical Periodontal Therapy on Glycemic Control and Periodontal Health in Diabetic Patients With Periodontitis (Randomized Controlled Clinical Trial)

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03783845
Enrollment
44
Registered
2018-12-21
Start date
2015-06-01
Completion date
2016-03-30
Last updated
2019-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Periodontitis, Generalized

Brief summary

Is the non-surgical periodontal therapy can improve glycemic control in type 2 diabetic patients with chronic periodontitis?

Detailed description

The aim of the present study was to monitor the clinical outcomes and the metabolic response of non-surgical periodontal therapy in patients with chronic periodontitis and uncontrolled type 2 diabetes. Regarding clinical and metabolic parameters at baseline, no differences were displayed between two groups. However, at 3-months follow-up period the patients within a test group were demonstrated better clinical outcomes than patients in a control group

Interventions

COMBINATION_PRODUCTamoxicillin 500mg and metronidazole 400mg

metronidazole 400mg and amoxicillin 500mg three times daily for two weeks

Sponsors

Taibah University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
40 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

Diagnosis of diabetes type 2 for more than five years Type 2 diabetes with HbA1c level from 7% to 9% at the last medical evaluation Diagnosis with chronic periodontitis

Exclusion criteria

Pregnancy * Alcoholism and smoking * Presence of any systemic disorders other than hypertension and diabetes * Diabetic major complications

Design outcomes

Primary

MeasureTime frameDescription
glycosylated haemoglobin (HbA1c)3 monthsBlood was taken from a peripheral vein to monitor HbA1c using high-performance liquid chromatography

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026